The vast majority of studies included in the review focused on comparing DHP calcium channel blockers with hypotensive drugs from other groups (e.g., angiotensin-converting-enzyme inhibitors [ACE-Is], angiotensin receptor blockers [ARBs], mineralocorticoid receptor antagonist [MRAs], thiazide diuretics), various substances in the DHP calcium channel blocker group, or using them in combination
2,7-dichlorofluorescin-diacetate (DCFDA) was used for reactive oxygen species (ROS) measurement
Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose
Thomas FC, Taskar K, Rudraraju V, Goda S, Thorsheim HR, Gaasch JA, Mittapalli RK, Palmieri D, Steeg PS et al (2009) Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer